Axim Biotechnologies, Inc.
AXIM· OTC
AXIMAxim Biotechnologies, Inc.
Quarterly figures for Axim Biotechnologies, Inc., with source filings when available.
54 quarters. Mar 31, 2011 to Jun 30, 2024. USD.
Axim Biotechnologies, Inc. has filed its 10-Q within 45 to 53 days of period end across its last 8 quarters. The 10-K runs 74 to 135 days.
Axim Biotechnologies, Inc. · CIK 1514946 · Engraved from SEC EDGAR
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Source trail |
|---|---|---|---|---|---|---|---|---|---|
| FY 2024 | |||||||||
| Q2 2024 | Jun 30, 2024 | — | Aug 19, 2024 | 50 d | 10-Q | $17.48K | +76.0% | -$0.01 | |
| Q1 2024 | Mar 31, 2024 | — | May 20, 2024 | 50 d | 10-Q | $52.98K | +616.2% | -$0.00 | |
| FY 2023 | |||||||||
| Q4 2023derived | Dec 31, 2023 | — | Apr 16, 2024 | 107 d | 10-K | $12.61K | +66.8% | — | |
| Q3 2023 | Sep 30, 2023 | — | Nov 20, 2023 | ||||||
| FY 2022 | |||||||||
| Q4 2022derived | Dec 31, 2022 | — | Apr 17, 2023 | 107 d | 10-K | $7.56K | +57.2% | — | |
| Q3 2022 | Sep 30, 2022 | — | Nov 14, 2022 | ||||||
| FY 2021 | |||||||||
| Q4 2021derived | Dec 31, 2021 | — | Apr 15, 2022 | 105 d | 10-K | $4.81K | — | — | |
| Q3 2021 | Sep 30, 2021 | — | Nov 22, 2021 | ||||||
| FY 2020 | |||||||||
| Q4 2020derived | Dec 31, 2020 | — | Apr 15, 2021 | 105 d | 10-K | $0.00 | −100.0% | — | |
| Q3 2020 | Sep 30, 2020 | — | Nov 20, 2020 | ||||||
| FY 2019 | |||||||||
| Q4 2019derived | Dec 31, 2019 | — | May 14, 2020 | 135 d | 10-K | $782.42K | +368.6% | — | |
| Q3 2019 | Sep 30, 2019 | — | Nov 14, 2019 | ||||||
| FY 2018 | |||||||||
| Q4 2018derived | Dec 31, 2018 | — | Apr 8, 2019 | 98 d | 10-K | $166.97K | +980.2% | — | |
| Q3 2018 | Sep 30, 2018 | — | Nov 14, 2018 | ||||||
| FY 2017 | |||||||||
| Q4 2017derived | Dec 31, 2017 | — | Mar 15, 2018 | 74 d | 10-K | $15.46K | +26.6% | — | |
| Q3 2017 | Sep 30, 2017 | — | Nov 20, 2017 | ||||||
| FY 2016 | |||||||||
| Q4 2016derived | Dec 31, 2016 | — | Apr 17, 2017 | 107 d | 10-K | $12.21K | −20.8% | — | |
| Q3 2016 | Sep 30, 2016 | — | Nov 21, 2016 | ||||||
| FY 2015 | |||||||||
| Q4 2015derived | Dec 31, 2015 | — | Apr 14, 2016 | 105 d | 10-K | $15.42K | — | — | |
| Q3 2015 | Sep 30, 2015 | — | Nov 23, 2015 | ||||||
| FY 2014 | |||||||||
| Q4 2014derived | Dec 31, 2014 | — | Apr 14, 2015 | 104 d | 10-K | — | — | — | |
| Q3 2014 | Sep 30, 2014 | — | Nov 14, 2014 | 45 d | 10-Q | ||||
| FY 2013 | |||||||||
| Q4 2013derived | Dec 31, 2013 | — | Mar 4, 2014 | 63 d | 10-K | — | — | — | |
| Q3 2013 | Sep 30, 2013 | — | Nov 18, 2013 | 49 d | 10-Q | ||||
| FY 2012 | |||||||||
| Q4 2012derived | Dec 31, 2012 | — | Apr 15, 2013 | 105 d | 10-K | $10.83K | +8.3% | — | |
| Q3 2012 | Sep 30, 2012 | — | Nov 19, 2012 | ||||||
| FY 2011 | |||||||||
| Q4 2011derived | Dec 31, 2011 | — | Apr 16, 2012 | 107 d | 10-K | $10.00K | — | — | |
| Q3 2011 | Sep 30, 2011 | — | Nov 17, 2011 | ||||||
| 51 d |
| 10-Q |
| $9.58K |
| +629.1% |
| $0.00 |
| Q2 2023 | Jun 30, 2023 | — | Aug 21, 2023 | 52 d | 10-Q | $9.93K | — | -$0.02 |
|---|
| Q1 2023 | Mar 31, 2023 | — | May 22, 2023 | 52 d | 10-Q | $7.40K | — | -$0.01 |
|---|
| 45 d |
| 10-Q |
| $1.31K |
| −83.8% |
| -$0.01 |
| Q2 2022 | Jun 30, 2022 | — | Aug 16, 2022 | 47 d | 10-Q | $0.00 | −100.0% | -$0.01 |
|---|
| Q1 2022 | Mar 31, 2022 | — | May 23, 2022 | 53 d | 10-Q | $0.00 | −100.0% | -$0.01 |
|---|
| 53 d |
| 10-Q |
| $8.13K |
| — |
| -$0.03 |
| Q2 2021 | Jun 30, 2021 | — | Aug 23, 2021 | 54 d | 10-Q | $14.88K | — | -$0.03 |
|---|
| Q1 2021 | Mar 31, 2021 | — | May 24, 2021 | 54 d | 10-Q | $32.65K | — | -$0.01 |
|---|
| 51 d |
| 10-Q |
| $0.00 |
| — |
| -$0.02 |
| Q2 2020 | Jun 30, 2020 | — | Aug 14, 2020 | 45 d | 10-Q | $0.00 | — | $0.00 |
|---|
| Q1 2020 | Mar 31, 2020 | — | Jun 29, 2020 | 90 d | 10-Q | — | — | -$0.03 |
|---|
| 45 d |
| 10-Q |
| — |
| — |
| -$0.01 |
| Q2 2019 | Jun 30, 2019 | — | Aug 14, 2019 | 45 d | 10-Q | — | — | -$0.03 |
|---|
| Q1 2019 | Mar 31, 2019 | — | May 15, 2019 | 45 d | 10-Q | $17.06K | +19.7% | -$0.04 |
|---|
| 45 d |
| 10-Q |
| $6.22K |
| −36.2% |
| -$0.02 |
| Q2 2018 | Jun 30, 2018 | — | Aug 14, 2018 | 45 d | 10-Q | $8.17K | +118.7% | -$0.03 |
|---|
| Q1 2018 | Mar 31, 2018 | — | May 15, 2018 | 45 d | 10-Q | $14.25K | −23.5% | -$0.05 |
|---|
| 51 d |
| 10-Q |
| $9.76K |
| +1.6% |
| -$0.03 |
| Q2 2017 | Jun 30, 2017 | — | Aug 21, 2017 | 52 d | 10-Q | $3.74K | −66.7% | -$0.01 |
|---|
| Q1 2017 | Mar 31, 2017 | — | May 22, 2017 | 52 d | 10-Q | $18.62K | +33.0% | -$0.01 |
|---|
| 52 d |
| 10-Q |
| $9.60K |
| −55.6% |
| -$0.07 |
| Q2 2016 | Jun 30, 2016 | — | Aug 22, 2016 | 53 d | 10-Q | $11.24K | −7.2% | -$0.05 |
|---|
| Q1 2016 | Mar 31, 2016 | — | May 23, 2016 | 53 d | 10-Q | $14.01K | — | -$0.02 |
|---|
| 54 d |
| 10-Q |
| $21.61K |
| — |
| -$0.04 |
| Q2 2015 | Jun 30, 2015 | — | Aug 19, 2015 | 50 d | 10-Q | $12.11K | — | -$0.04 |
|---|
| Q1 2015 | Mar 31, 2015 | — | May 13, 2015 | 43 d | 10-Q | $0.00 | −100.0% | -$0.02 |
|---|
| $0.00 |
| −100.0% |
| $0.00 |
| Q2 2014 | Jun 30, 2014 | — | Aug 19, 2014 | 50 d | 10-Q | $0.00 | −100.0% | $0.00 |
|---|
| Q1 2014 | Mar 31, 2014 | — | May 20, 2014 | 50 d | 10-Q | $2.50K | −76.9% | $0.00 |
|---|
| $10.83K |
| ±0.0% |
| $0.00 |
| Q2 2013 | Jun 30, 2013 | — | Aug 14, 2013 | 45 d | 10-Q | $10.83K | +0.0% | $0.00 |
|---|
| Q1 2013 | Mar 31, 2013 | — | May 15, 2013 | 45 d | 10-Q | $10.83K | ±0.0% | $0.00 |
|---|
| 50 d |
| 10-Q |
| $10.83K |
| — |
| $0.00 |
| Q2 2012 | Jun 30, 2012 | — | Aug 14, 2012 | 45 d | 10-Q | $10.83K | — | $0.00 |
|---|
| Q1 2012 | Mar 31, 2012 | — | May 17, 2012 | 47 d | 10-Q | $10.83K | — | $0.00 |
|---|
| 48 d |
| 10-Q |
| $0.00 |
| — |
| $0.00 |
| Q2 2011 | Jun 30, 2011 | — | — | — | — | $0.00 | — | $0.00 |
|---|
| Q1 2011 | Mar 31, 2011 | — | — | — | — | $0.00 | — | $0.00 |
|---|
